Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High low-density lipoprotein cholesterol levels in people with HIV by individual cardiovascular risk: A retrospective observational study.
Carrozzo G, Caloni B, Giacomelli A, Oreni L, Caronni S, Lazzarin S, Poloni A, Pagano S, Colombo ML, Beltrami M, Casalini G, Maggioni AP, Gervasoni C, Ridolfo AL, Antinori S. Carrozzo G, et al. Among authors: antinori s. Int J Cardiol. 2024 Nov 19;420:132742. doi: 10.1016/j.ijcard.2024.132742. Online ahead of print. Int J Cardiol. 2024. PMID: 39566586
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.
Ciccullo A, Baldin G, Cervo A, Moschese D, Lagi F, Cossu MV, Grimaldi A, Giacomelli A, Rusconi S, Sterrantino G, Borghetti A, Antinori S, Mussini C, Di Giambenedetto S. Ciccullo A, et al. Among authors: antinori s. J Antimicrob Chemother. 2024 Oct 30:dkae392. doi: 10.1093/jac/dkae392. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39478330
Impact of early antiviral therapy on SARS-CoV-2 clearance time in high-risk COVID-19 subjects: A propensity score matching study.
Colaneri M, Fama F, Fassio F, Holmes D, Scaglione G, Mariani C, Galli L, Lai A, Antinori S, Gori A, Riva A, Schiavini M; Ospedale Luigi Sacco “COVID-19 Hotspot” study group. Colaneri M, et al. Among authors: antinori s. Int J Infect Dis. 2024 Oct 10;149:107265. doi: 10.1016/j.ijid.2024.107265. Online ahead of print. Int J Infect Dis. 2024. PMID: 39393523 Free article.
Response to the Letter to the Editor Regarding "Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study".
Canuti M, Fassio F, Genovese C, Giacomelli A, Ridolfo AL, Asperges E, Albi G, Bruno R, Antinori S, Muscatello A, Mariani B, Canetta C, Blasi F, Bandera A, Gori A, Colaneri M. Canuti M, et al. Among authors: antinori s. Infect Dis Ther. 2024 Nov;13(11):2471-2474. doi: 10.1007/s40121-024-01047-5. Epub 2024 Oct 1. Infect Dis Ther. 2024. PMID: 39352650 Free PMC article. No abstract available.
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona).
Mazzotta V, Nozza S, Lanini S, Moschese D, Tavelli A, Rossotti R, Fusco FM, Biasioli L, Matusali G, Raccagni AR, Mileto D, Maci C, Lapadula G, Di Biagio A, Pipitò L, Tamburrini E, Monforte AD, Castagna A, Antinori A; mpox-Icona study group. Mazzotta V, et al. EBioMedicine. 2024 Sep;107:105289. doi: 10.1016/j.ebiom.2024.105289. Epub 2024 Aug 22. EBioMedicine. 2024. PMID: 39178746 Free PMC article.
378 results